GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Total Debt per Share

Biotage AB (Biotage AB) Total Debt per Share : $0.48 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Total Debt per Share?

$0.48 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Biotage AB's Total Debt Per Share for the quarter that ended in Mar. 2024 was $0.48.


Biotage AB Total Debt per Share Historical Data

The historical data trend for Biotage AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Total Debt per Share Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.30 0.34 0.32 0.32

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.43 0.46 0.32 0.48

Biotage AB Total Debt per Share Calculation

Biotage AB's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Biotage AB's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Biotage AB's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 10-25-2021

Change in number of shares and votes

By PRNewswire PRNewswire 12-30-2021

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021

Biotage - Change in number of shares and votes

By PRNewswire PRNewswire 10-29-2021

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022